Agios Pharmaceuticals Inc. buy BiotechBee
Start price
10.12.23
/
70%
€20.60
Target price
30.11.25
€26.00
Performance (%)
81.55%
End price
14.12.24
€37.40
Summary
This prediction ended on 14.12.24 with a price of €37.40. With a performance of 81.55% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Agios Pharmaceuticals Inc. where he still thinks Agios Pharmaceuticals Inc. is a Buy. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Agios Pharmaceuticals Inc. | 16.822% | 16.822% | -55.357% |
| iShares Core DAX® | 3.608% | -2.170% | 22.760% |
| iShares Nasdaq 100 | 4.362% | -1.854% | 11.279% |
| iShares Nikkei 225® | 3.371% | -2.409% | 17.237% |
| iShares S&P 500 | 3.596% | -0.427% | 4.590% |
According to BiotechBee what are the pros and cons of Agios Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
In the thread Trading Agios Pharmaceuticals Inc.
Current prediction by BiotechBee for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.00
24.11.25
24.11.25
€30.00
31.03.28
31.03.28
7.83%
22:26
22:26
Could be very worthwhile Investment >20% year
